Gujarat Themis Biosyn Limited (GUJTHEM) — regulation 31
Pharmaceutical Business Group (India) Limited disclosed an indirect encumbrance on its 47.02% stake in Gujarat Themis Biosyn Limited after Vividhmargi Investments created a pledge over 25,24,245 shares and a non-disposal undertaking over 21,57,855 shares of PBGIL on June 29, 2026, resulting in an indirect encumbrance on 5,12,40,000 shares held by PBGIL.
About Gujarat Themis Biosyn Limited (GUJTHEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GUJTHEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GUJTHEM — Free💡 Ask AI about this filing
📊 More GUJTHEM filings
- 🔴 Insider Trading — 15 July 2026 Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares...
- Announcement — 13 July 2026 Gujarat Themis Biosyn Limited disclosed that it has amicably settled a commercial arbitration disput...
- 🟡 Voting Results — 10 July 2026 Gujarat Themis Biosyn Limited announced voting results for special resolutions passed via e-voting o...
- share transfer — 10 July 2026 Gujarat Themis Biosyn Limited received a SEBI-mandated certificate from MUFG Intime India confirming...
- 🔴 Insider Trading — 2 July 2026 Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares...
🔥 Also filed on 14 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GUJTHEM files new disclosures
Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUJTHEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research